Drug to induce thrombocytopenia. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Blood Platelets Megakaryocytes Bone Marrow

Organisms2

Phlebovirus Orthobunyavirus

Diseases45

Thrombocytopenia Purpura, Thrombocytopenic, Idiopathic Thrombocytopenia, Neonatal Alloimmune Purpura, Thrombocytopenic Leukopenia Disseminated Intravascular Coagulation Pregnancy Complications, Hematologic Hemorrhage Neutropenia Bunyaviridae Infections Purpura, Thrombotic Thrombocytopenic Wiskott-Aldrich Syndrome Blood Platelet Disorders Hemorrhagic Disorders Splenomegaly Hematologic Diseases Hemolytic-Uremic Syndrome Thrombocytosis Thrombosis Anemia Hypersplenism Autoimmune Diseases Pancytopenia Anemia, Hemolytic, Autoimmune Antiphospholipid Syndrome Purpura Jacobsen Distal 11q Deletion Syndrome Neoplasms Syndrome Bernard-Soulier Syndrome Phlebotomus Fever Thrombotic Microangiopathies Severe Dengue Anemia, Hemolytic Bone Marrow Diseases Lupus Erythematosus, Systemic Acute Disease Intracranial Hemorrhages Blood Coagulation Disorders Nausea Lung Neoplasms Fever HELLP Syndrome Recurrence Primary Myelofibrosis

Chemicals and Drugs51

Antigens, Human Platelet Thrombopoietin Platelet Factor 4 Receptors, Thrombopoietin Heparin Pipecolic Acids Immunoglobulins, Intravenous Anticoagulants Autoantibodies Deoxycytidine Isoantibodies Carboplatin Interleukin-11 Cisplatin Immunoglobulin G Platelet Glycoprotein GPIIb-IIIa Complex Quinine Antineoplastic Agents Antibodies Danazol Integrin beta3 Wiskott-Aldrich Syndrome Protein Platelet Glycoprotein GPIb-IX Complex Rho(D) Immune Globulin Topotecan Antibodies, Monoclonal Hirudins Quinidine Organoplatinum Compounds HLA-DRB3 Chains Platelet Membrane Glycoproteins Antibodies, Monoclonal, Murine-Derived Hydrazines Recombinant Proteins Paclitaxel Dacarbazine Platelet Aggregation Inhibitors Heparin, Low-Molecular-Weight Platelet Membrane Glycoprotein IIb Granulocyte Colony-Stimulating Factor Hematologic Agents Cyclophosphamide Immunologic Factors Oxyquinoline Ifosfamide Immunoglobulin Fab Fragments Antineoplastic Agents, Alkylating Fluorouracil Pyrazines Etoposide Antibodies, Anticardiolipin

Analytical, Diagnostic and Therapeutic Techniques and Equipment23

Platelet Count Platelet Transfusion Splenectomy Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Infusions, Intravenous Blood Cell Count Maximum Tolerated Dose Drug Evaluation Retrospective Studies Blood Coagulation Tests Plasma Exchange Hirudin Therapy Survival Analysis Fatal Outcome Bleeding Time Salvage Therapy Survival Rate Bone Marrow Examination Combined Modality Therapy Leukocyte Count Disease-Free Survival

Phenomena and Processes11

Platelet Count Thrombopoiesis Blood Cell Count Maximum Tolerated Dose Platelet Activation Platelet Aggregation Dose-Response Relationship, Drug Bleeding Time Time Factors Hematopoiesis Leukocyte Count

Disciplines and Occupations1

Information Science2

Fatal Outcome Survival Rate

Named Groups1

Infant, Newborn

Health Care6

Treatment Outcome Retrospective Studies Survival Analysis Fatal Outcome Survival Rate Disease-Free Survival

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care

Thrombocytopenia Platelet Count Purpura, Thrombocytopenic, Idiopathic Thrombocytopenia, Neonatal Alloimmune Platelet Transfusion Blood Platelets Antigens, Human Platelet Purpura, Thrombocytopenic Megakaryocytes Thrombopoietin Platelet Factor 4 Receptors, Thrombopoietin Heparin Splenectomy Phlebovirus Leukopenia Thrombopoiesis Disseminated Intravascular Coagulation Pregnancy Complications, Hematologic Pipecolic Acids Hemorrhage Neutropenia Bunyaviridae Infections Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Immunoglobulins, Intravenous Drug Administration Schedule Purpura, Thrombotic Thrombocytopenic Wiskott-Aldrich Syndrome Anticoagulants Infusions, Intravenous Blood Platelet Disorders Blood Cell Count Hemorrhagic Disorders Splenomegaly Autoantibodies Hematologic Diseases Deoxycytidine Hemolytic-Uremic Syndrome Thrombocytosis Isoantibodies Thrombosis Carboplatin Anemia Hypersplenism Interleukin-11 Bone Marrow Cisplatin Maximum Tolerated Dose Immunoglobulin G Platelet Glycoprotein GPIIb-IIIa Complex Quinine Antineoplastic Agents Drug Evaluation Platelet Activation Antibodies Autoimmune Diseases Pancytopenia Anemia, Hemolytic, Autoimmune Platelet Aggregation Antiphospholipid Syndrome Purpura Dose-Response Relationship, Drug Danazol Retrospective Studies Integrin beta3 Jacobsen Distal 11q Deletion Syndrome Wiskott-Aldrich Syndrome Protein Platelet Glycoprotein GPIb-IX Complex Rho(D) Immune Globulin Neoplasms Syndrome Topotecan Blood Coagulation Tests Antibodies, Monoclonal Hirudins Bernard-Soulier Syndrome Phlebotomus Fever Quinidine Organoplatinum Compounds Orthobunyavirus Thrombotic Microangiopathies Plasma Exchange Hematology Hirudin Therapy HLA-DRB3 Chains Severe Dengue Survival Analysis Platelet Membrane Glycoproteins Anemia, Hemolytic Antibodies, Monoclonal, Murine-Derived Fatal Outcome Hydrazines Recombinant Proteins Bleeding Time Bone Marrow Diseases Paclitaxel Lupus Erythematosus, Systemic Time Factors Salvage Therapy

No FAQ available that match "drug to induce thrombocytopenia"